Fast tils to treat metastatic cancer patients with pleural disease
Active Project Grant Awarded Last action
- Award ID
- HT94252411067
- Recipient
-
Allegheny Singer Research Institute UEI F7V2DLFLWJN9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,165,991
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 49% complete
- Place of performance
- Allegheny-West, PA 15212, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $2,165,991 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Allegheny Singer Research Institute (AHN Research Institute) to advance research on T-Cell Infused Lymphocyte Therapy (TILS) for treating metastatic cancer in patients with pleural disease. The grant, awarded on November 1, 2024, will fund a multi-year research initiative to explore this innovative cancer treatment approach, with a planned completion date of October 31, 2028. As a not-for-profit medical research organization, the Allegheny Singer Research Institute has an extensive portfolio of federal grants and contracts, including significant awards from agencies like the Department of Defense, National Institutes of Health, and Substance Abuse and Mental Health Services Administration for research on various healthcare challenges and emerging medical technologies.
Quick answers
Who received award HT94252411067?
HT94252411067 was awarded to Allegheny Singer Research Institute by Defense Health Agency (Department of Defense) on November 1, 2024.
How much is award HT94252411067 worth?
$2,165,991 has been obligated on HT94252411067.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award